SPECIAL NOTICE
99 -- Maintaining an Embryonated Egg Supply for the Non-Seasonal Production of Pandemic Vaccine
- Notice Date
- 11/25/2024 1:05:04 PM
- Notice Type
- Special Notice
- Contracting Office
- ASPR BARDA DIV CONTRACTS MGMT & ACQ Washington DC 20515 USA
- ZIP Code
- 20515
- Response Due
- 12/10/2024 1:00:00 PM
- Archive Date
- 12/13/2024
- Point of Contact
- Kevin Andralliski
- E-Mail Address
-
kevin.andralliski@hhs.gov
(kevin.andralliski@hhs.gov)
- Description
- The Contractor shall maintain a dynamic raw material supply chain of embryonated hen eggs, for manufacturing of its pandemic influenza vaccine. The Contractor shall provide a domestic (Contiguous United States) network of incubation facilities and flocks, to provide a year-round supply of embryonated eggs developed specifically for a FDA-licensed seasonal and possible pandemic influenza vaccine. In addition, the Contractor shall have the ability to produce a minimum of ten (10) million monovalent influenza vaccine final finished container, including losses, doses per week, in the case of a declared public health emergency. The Egg Supply program also requires an Avian Influenza (High or Low Pathogenicity) Plan for the Contractor�s sites and personnel, as well as a plan for dynamic testing of flocks and facilities to mitigate risks during High (or Low) Pathogenicity Avian Influenza conditions.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/40db79b96bf543ffa9b2862f5bda8643/view)
- Place of Performance
- Address: Swiftwater, PA, USA
- Country: USA
- Country: USA
- Record
- SN07274407-F 20241127/241125230105 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |